Reduning injection for chikungunya fever
Part of Infections clinical trials.
This trial tests whether Reduning injection can safely treat chikungunya fever. It is for adults who have had a fever for less than 48 hours and have moderate symptoms like muscle pain, joint pain, or rash.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chikungunya fever or are suspected to have it.
- Your fever started within the last 48 hours and your temperature is 38.0°C (100.4°F) or higher, even after taking fever-reducing medicine.
- You have at least one moderate or severe symptom like headache, muscle aches, nausea, joint pain or swelling, or rash that started within the last 72 hours.
- You are between 18 and 70 years old.
- You do not have other conditions like dengue, COVID-19, or chronic arthritis, and you are not pregnant or planning pregnancy within 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well Chinese medicine, Western medicine, or a mix of both works for people with chikungunya fever. It's a real-world study, meaning it follows what happens in everyday medical care, to see which approach helps patients feel better faster.
This study tests a new vaccine to see if it's safe and helps protect against chikungunya virus (a mosquito-borne illness causing fever and joint pain). It's for healthy adults ages 18 to 60 who haven't recently traveled to areas with similar viruses or received certain other vaccines.
This trial tests whether giving two vaccines (one for dengue, one for chikungunya) at the same time is as safe and effective as giving them separately. It may be a good option if you haven't been exposed to these viruses and are generally healthy.
This trial tests an experimental chikungunya vaccine (made from a virus-like particle) to see if it prevents the disease. It is for healthy teens and adults who have not had chikungunya before.
This study tests a new vaccine to protect against chikungunya virus, a disease spread by mosquitoes that causes fever and joint pain. The study measures how well your immune system responds to the vaccine and tracks any side effects.
This study tests a vaccine for chikungunya virus in children aged 1 to 12. It aims to see if the vaccine is safe and helps the body build protection against the virus.
Hear when a new Chikungunya Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.